Canopy Growth CORP 8-K filings

Canopy Growth has exercised its option to acquire Acreage Holdings, Inc., moving forward with the acquisition by Canopy USA.

Canopy Growth Corporation announced a 7% year-over-year increase in net revenue for Q4 FY2024, driven by strong performance in Storz & Bickel and Canada medical cannabis.

Canopy Growth Corporation has extended the deadline for its acquisition of Acreage Holdings' Class D subordinate voting shares to June 17, 2024, marking the eighth amendment to their existing agreement.

Canopy Growth Corporation has announced a new financing agreement that includes approximately US$50 million in gross proceeds and the extension of C$27.5 million in debt from 2025 to 2029.

Canopy Growth Corporation has extended the deadline for its acquisition of Acreage Holdings' Class D subordinate voting shares to May 9, 2024, due to ongoing share exchange processes.

Canopy Growth Corporation has eliminated $100 million in debt and restructured its board following a share exchange agreement with Constellation Brands, Inc.

Canopy Growth Corporation's shareholders have approved the creation of a new class of exchangeable shares, a key step in the company's strategy to enter the U.S. cannabis market.

Canopy Growth Corporation has extended the deadline for its acquisition of Acreage Holdings' Class D subordinate voting shares to April 30, 2024, as part of an ongoing arrangement.

Canopy Growth achieved its third consecutive quarter of sequential revenue growth in its Canadian cannabis business and a record quarter for medical sales, alongside significant margin improvements.

Canopy Growth Corporation has successfully raised approximately US$35 million through a private placement to strengthen its financial position and reduce debt.

Canopy Growth Corporation terminated a $30 million private placement due to a third-party delay impacting closing requirements, but maintains sufficient liquidity.